Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8906938 C5aR antagonists

Patent 8906938 was granted and assigned to ChemoCentryx on December, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

ChemoCentryx

Current Assignee

ChemoCentryx

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

89069380

Patent Inventor Names

Hiroko Tanaka0

Jay P. Powers0

Ju Yang0

Kevin Lloyd Greenman0

Manmohan Reddy Leleti0

Pingchen Fan0

Yandong Li0

Yibin Zeng0

Date of Patent

December 9, 2014

Patent Application Number

138942090

Date Filed

May 14, 2013

Patent Citations Received

‌

US Patent 11951214 Capsule formulations

‌

US Patent 11773091 6-5 fused rings as C5a inhibitors

‌

US Patent 11779576 Method of treating C3 glomerulopathy

Patent Primary Examiner

‌

Celia Chang

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8906938 C5aR antagonists

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API